Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer

NCT02030769 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Neoplasms

Interventions

DRUG: Pronase
DRUG: Control

Sponsor

Xijing Hospital of Digestive Diseases

Collaborators

[object Object]